Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Former Ghanaian President Named World Food Programme Ambassador
John Kofi Agyekum Kufuor, a former president of Ghana, has been named a global ambassador against hunger for the U.N."s World Food Programme (WFP), Xinhua reports. According to the news service, Kufuor will "help to underline the importance of fighting hunger on several fronts - by investing in long-term agricultural development, but also by funding WFP"s work in tackling urgent hunger needs and helping the hungry poor to access affordable and nutritious food" (Ooko, 7/20).
generic viagra online
WFP Appeals For $23M To Help Women, Children In Yemen
The World Food Programme (WFP) issued an urgent appeal on Tuesday for $23 million in "financial support from international donors for food aid to Yemen specifically targeted at women and children," AFP/Google.com reports. The agency said that the "figure represents 42 percent of the 55 million dollars that it needs for the current year to improve the nutrition of more than 1.6 million vulnerable people in Yemen," the news service writes.
plastic surgery before after
News of the day
IRIN Examines PEPFAR Funding Of IDU Programs
IRIN examines a recent comment piece in the journal Lancet that argues PEPFAR can do more to prevent the spread of HIV among injecting drug users (IDUs) in Africa (IRIN, 6/24). Although PEPFAR has helped to provide "antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than $18 billion on the continent," it has failed to reach "thousands of injecting drug users in PEPFAR countries in Africa, many of whom have HIV," according to the authors of the Lancet article (Kaiser Global Health Policy Report, 6/19).
Medical Devices

European Urology July Issue Reviews Prostate Screening Studies

The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) In the editorial, Professor Holmberg writes that "The studies illustrate that the price to pay for 20% reduction in prostate cancer deaths is high; overdiagnosis and overtreatment are great problems. The answers lie in improving the PSA test or finding biomarkers that effectively separate aggressive cancers from slow-growing ones. We identify some priorities in the discussion about PSA testing." Another article of interest in this issue is "Testosterone and Prostate Cancer: Revisiting Old Paradigms" by H. Isbarn et al. The notion that pathologic prostate growth, benign or malignant, can be stimulated by androgens is a commonly held belief - but one without scientific basis. In the article, Dr. Isbarn writes that, "We therefore conducted a Medline search to identify articles addressing the relationship between testosterone and the risk of prostate cancer development. Although large prospective studies addressing the long-term effect of testosterone treatment are needed to either refute or corroborate the hypothesis, the available literature strongly suggests that testosterone treatment neither increases the risk of prostate cancer diagnosis in normal men nor causes cancer recurrence in men who were successfully treated for prostate cancer." Next month, European Urology will publish the EAU position statement on screening for prostate cancer which takes into consideration the recent scientific information on randomised screening studies on prostate cancer (Schrç¶der et al, NEJM 2009). The EAU adopts the conclusions of the ERSPC study and recognises the benefit of screening in terms of mortality reduction, as well as the adverse effects of overdiagnosis and overtreatment of prostate cancers which could be quantified for the first time in the setting of a randomised screening study. Lindy Brouwer European Association of Urology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009